ABSTRACT
OBJECTIVES: The objectives of this study were to detect those characteristics that were specifically associated with infection or colonization by Acinetobacter baumannii, describe the clinical manifestations of those patients in whom the infection was detected in intensive care unit (ICU) or non-ICU wards, and analyze the prognosis-associated factors in patients from whom A. baumannii was isolated. PATIENTS AND METHODS: A sample of 122 patients from whom A. baumannii was recovered during an endemic period in a teaching hospital was included. Only those cases in which A. baumannii was recovered as the unique microbe were considered. Demographic data; ward of admission; intrinsic and extrinsic risk factors for infection or colonization; chronic underlying condition severity, as evaluated by the McCabe classification or Charlson index and Acute Physiology and Chronic Health Evaluation (APACHE) II score; and clinical manifestations were analyzed to differentiate specific characteristics of colonized or infected patients. Factors independently associated with the mortality at 30 days were also analyzed by Cox regression. RESULTS: A total of 73 (60%) patients were colonized and 49 (40%) individuals were infected with A. baumannii. A non-fatal McCabe class (when compared to ultimately and rapidly fatal), days of hospitalization prior to isolation of A. baumannii, and present ICU admission were associated with the diagnosis of infection. The more frequent clinical picture was respiratory infection (tracheobronchitis, 16 [33%] cases; pneumonia, 27 [55%] cases). Mortality at 30 days was 24% (n=29). A non-fatal McCabe class (Exp[B] 2.44, 95% confidence interval [CI] 1.05-5.66, p=0.039) and the absence of infection (Exp[B] 2.75, 95% CI 1.18-6.38, p=0.019) were independently associated with survival. CONCLUSION: Parameters associated with infection by A. baumannii in an endemic situation are the admission at ICU and the number of days of hospitalization. Mortality of patients from whom A. baumannii was isolated was independently influenced by the chronic underlying basal state and the presence of infection by A. baumannii.
ABSTRACT
OBJECTVE: To achieve well-being in patients in Palliative Care is required to know which are the most common symptoms, which are the drugs used for relief, which are the routes of administration of drugs that are suitable, how effective the drugs are and what incompatibilities, interactions and adverse effects occur. The aim of this article is to review the relevant issues in the management of the drugs commonly used by nursing in Palliative Care and presenting recommendations to clinical practice. METHODOLOGY: Management interventions drugs for nurses in Palliative Care recommended by the scientific literature after a search of Scopus, CINAHL, Medline, PubMed, UpToDate and Google Scholar are selected. RESULTS: The oral route is the choice for patients in palliative situation and subcutaneous route when the first is not available. The symptoms, complex, intense and moody, should be systematically reevaluated by the nurse, to predict when a possible decompensation of it needing extra dose of medication. DISCUSSION: Nurses must be able to recognize the imbalance of well-being and act quickly and effectively, to get relief to some unpleasant situations for the patient as the pain symptoms, dyspnea or delirium. For the proper administration of rescue medication, the nurse should know the methods of symptomatic evaluation, pharmacokinetics and pharmacodynamics of drugs, the time intervals to elapse between different rescues and nccocc rocnnnco t thocm
Subject(s)
Drug Therapy , Palliative Care/standards , Drug Administration Routes , Drug Interactions , Humans , Infusions, Subcutaneous , Practice Guidelines as TopicABSTRACT
Objetivo. Para lograr el bienestar del paciente en Cuidados Paliativos (CP) es obligado conocer cuáles son los síntomas más frecuentes, qué fármacos se utilizan para su alivio, cuáles son las vías de administración, qué efectividad demuestran y qué incompatibilidades, interacciones y efectos adversos. El objetivo de este artículo es revisar las cuestiones relevantes en el manejo enfermero de los fármacos comúnmente usados en CP y presentar recomendaciones orientadas a la práctica clínica. Metodología. Se seleccionan las intervenciones sobre manejo enfermero de fármacos en CP recomendadas por la literatura científica tras una búsqueda realizada en Scopus, CINAHL, Medline-Pubmed, UpToDate y Google Académico. Resultados. La vía oral es la de elección en el paciente en situación paliativa, y la subcutánea cuando no está disponible la primera. La sintomatología, compleja, intensa y cambiante, debe reevaluarse de forma sistemática por el profesional de enfermería, y contrarrestar posibles descompensaciones impredecibles de la misma con una dosis extra de medicación. Discusión. El personal de enfermería ha de saber reconocer la descompensación y actuar rápida y eficazmente en el alivio de una sintomatología tan desagradable para el paciente como el dolor, la disnea o el delírium. Para la administración correcta de la medicación de rescate, el personal de enfermería debe conocer los métodos de evaluación sintomática, las características farmacocinéticas y farmacodinámicas de los fármacos, los intervalos de tiempo que deben transcurrir entre diferentes rescates y evaluar la respuesta a los mismos (AU)
Objective. To achieve well-being in patients in Palliative Care is required to know which are the most common symptoms, which are the drugs used for relief, which are the routes of administration of drugs that are suitable, how effective the drugs are and what incompatibilities, interactions and adverse effects occur. The aim of this article is to review the relevant issues in the management of the drugs commonly used by nursing in Palliative Care and presenting recommendations to clinical practice. Methodology. Management interventions drugs for nurses Palliative Care recommended by the scientific literature after a search of Scopus, CINAHL, Medline, PubMed, UpToDate and Google Scholar are selected. Results. The oral route is the choice for patients in palliative situation and subcutaneous route when the first is not available. The symptoms, complex, intense and moody, should be systematically reevaluated by the nurse, to predict when a posible decompensation of it needing extra dose of medication. Discussion. Nurses must be able to recognize the imbalance of well-being and act quickly and effectively, to get relief to some unpleasant situations for the patient as the pain symptoms, dyspnea or delirium. For the proper administration of rescue medication, the nurse should know the methods of symptomatic evaluation, pharmacokinetics and pharmacodynamics of drugs, the time intervals to elapse between different rescues and assess response to them (AU)
